AlphaGrep UK Ltd’s Patterson-UTI PTEN Stock Holding History

AlphaGrep UK Ltd’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$575K	Buy	53,135 +26,815	+102%	+$230K	0.17%	181
2025 Q4	$161K	Buy	+26,320	New	+$157K	0.05%	634

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AlphaGrep UK Ltd's PTEN Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Patterson-UTI (PTEN) stake by 102% in Q1 2026, buying an estimated $230K and bringing the position to 53,135 shares worth $575K. The position accounts for 0.17% of the portfolio, ranked #181.

AlphaGrep UK Ltd first reported a position in PTEN in Q4 2025 and has held it in 2 quarters since. 413 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

AlphaGrep UK Ltd held 53,135 shares of Patterson-UTI worth $575K as of Q1 2026.
AlphaGrep UK Ltd bought 26,815 Patterson-UTI shares in Q1 2026, an estimated $230K.
Patterson-UTI made up 0.17% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #181 holding.
AlphaGrep UK Ltd first reported a position in Patterson-UTI in Q4 2025 and has held it in 2 quarters since.
413 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.